sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
24-Jul-2016 16:33
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1001-1025 out of 1284.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>

Public Release: 30-Dec-2014
PLOS Medicine
Malaria combination drug therapy for children
A drug combination of artemisinin-naphthoquine should be considered for the treatment of children with uncomplicated malaria in settings where multiple parasite species cause malaria according to Tim Davis from University of Western Australia, Fremantle, Australia and colleagues in new research published in this week's PLOS Medicine.
National Health and Medical Research Council

Contact: Maya Sandler

Public Release: 29-Dec-2014
Annals of Internal Medicine
Annals of Internal Medicine tip sheet for Dec. 30, 2014
Editorials being published in the next issue of Annals of Internal Medicine include 'Medical ethicists offer recommendations for delivering life-sustaining therapies to Ebola patients' and 'Former Surgeon General discusses credibility and influence of 'The Nation's Doctor'.'

Contact: Megan Hanks
American College of Physicians

Public Release: 23-Dec-2014
Grant supports use of data science to optimize HIV treatment monitoring
A Brown University biostatistician and an infectious disease specialist have received a $3.5-million grant to develop new ways to use data from patient health records to optimize effectiveness of HIV treatment where resources are limited, such as in the developing world. They will work with an HIV care program in Kenya that provides healthcare to more than 130,000 patients a year.
National Institutes of Health

Contact: David Orenstein
Brown University

Public Release: 23-Dec-2014
The Lancet
Scientists report on trial of early-generation Ebola, Marburg vaccine candidates
esults of an early-stage clinical trial of two experimental vaccines against Ebola and Marburg viruses -- the first to be completed in an African country -- showed that they were safe and induced immune responses in healthy Ugandan adult volunteers.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 23-Dec-2014
Maternal supplementation with multiple micronutrients compared with iron-folic acid
In Bangladesh, daily maternal supplementation of multiple micronutrients compared to iron-folic acid before and after childbirth did not reduce all-cause infant mortality to age 6 months, but did result in significant reductions in preterm birth and low birth weight, according to a study in the Dec. 24/31 issue of JAMA.

Contact: Stephanie Desmon
The JAMA Network Journals

Public Release: 22-Dec-2014
Proceedings of the National Academy of Sciences
Study: Extra income boosts health of elderly in poor countries
Boosting the incomes of poor, elderly residents in developing countries can significantly improve their health and well-being, particularly in lung function and memory, a new study shows.
State of Yucatan, NIH/National Institute on Aging, RAND Corporation

Contact: Merrill Balassone
University of Southern California

Public Release: 21-Dec-2014
Lancet Global Health
IMF lending undermined healthcare provision in Ebola-stricken West Africa
Researchers criticize reforms advocated by the IMF for chronically under-funded and insufficiently staffed health systems in Guinea, Liberia and Sierra Leone. They say these policies contributed to 'lack of preparedness' of West African health systems to cope with disease and emergencies such as Ebola.

Contact: Alexander Kentikelenis
University of Cambridge

Public Release: 18-Dec-2014
Journal of Clinical Endocrinology and Metabolism
Urban stressors may contribute to rising rate of diabetes in developing nations
As people in developing nations relocate from rural areas to cities, the increased stress is affecting their hormone levels and making them more susceptible to diabetes and other metabolic disorders, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Contact: Jenni Glenn Gingery
The Endocrine Society

Public Release: 18-Dec-2014
PLOS Genetics
Fast-changing genes help malaria to hide in the human body
A new study, which shows how malaria parasites behave when they live in human red blood cells, could explain why the deadly infection has proved so hard to beat. Scientists have found that Plasmodium falciparum parasites can rapidly change the proteins on the surface of their host cells in order to hide from the immune system. Around a million new and unrecognizable surface proteins can be created in every infected human every two days.
Wellcome Trust, Medical Research Council

Contact: Mary Clarke
Wellcome Trust Sanger Institute

Public Release: 17-Dec-2014
The Lancet
Life expectancy increases globally as death toll falls from major diseases
People are living much longer worldwide than they were two decades ago, as death rates from infectious diseases and cardiovascular disease have fallen, according to a new, first-ever journal publication of country-specific cause-of-death data for 188 countries.

Contact: Rhonda Stewart
Institute for Health Metrics and Evaluation

Public Release: 16-Dec-2014
Neglected disease research in Lao PDR -- capacity building in Burundi
This year, the R. Geigy Foundation in Basel, Switzerland, confers two awards: one to the Laotian scientist Somphou Sayasone, the other to the Swiss TPH Jubilee Project 'Connecting the Dots.' The value of the prizes awarded is 10,000 CHF and 70,000 CHF, respectively. With its awards the RGS recognizes excellent achievements in neglected disease research in South-East Asia and capacity building in Burundi.

Contact: Christian Heuss
Swiss Tropical and Public Health Institute

Public Release: 16-Dec-2014
DNDi receives US$10 million from USAID to develop new drugs for neglected filaria patients
The Drugs for Neglected Diseases initiative has been awarded US$ 10 million by the United States Agency for International Development to develop new treatments for onchocerciasis, better known as river blindness, and lymphatic filariasis, better known as elephantitis -- the first-ever USAID grant for neglected tropical disease research and development.

Contact: Violaine Dallenbach
Drugs for Neglected Diseases Initiative

Public Release: 16-Dec-2014
Reproductive Sciences
Men in recovery from Ebola should wear condoms for at least 3 months
A new article reports that despite a clear lack of research on male survivors of Ebola, the current recommended practice of waiting at least three months after recovery to have unprotected sex should be upheld. This study was published today in Reproductive Sciences, a SAGE journal.

Contact: Camille Gamboa

Public Release: 16-Dec-2014
Clinical Infectious Diseases
Yale researchers reveal Ebola virus spreads in social clusters
An analysis of the ongoing Ebola outbreak reveals that transmission of the virus occurs in social clusters, a finding that has ramifications for case reporting and the public health.
National Institutes of Health, Santa Fe Institute, Omidyar Group

Contact: Ziba Kashef
Yale University

Public Release: 16-Dec-2014
PLOS Medicine
Home- vs. mobile clinic-based HIV testing and counseling in rural Africa
Home- and community-based HIV testing and counselling services can achieve high participation uptake in rural Africa but reach different populations within a community and should be provided depending on the groups that are being targeted, according to new research published in this week's PLOS Medicine by Niklaus Labhardt from the Swiss Tropical and Public Health Institute, and colleagues from SolidarMed, a Swiss non-governmental Organization for Health in Africa.

Contact: Maya Sandler

Public Release: 15-Dec-2014
UTMB's Sealy Center on Aging re-designated WHO/PAHO Collaborating Center
The world experts on aging research at the University of Texas Medical Branch at Galveston have again received an international designation acknowledging their special niche in an area that grows more complex every day as the elderly population explodes worldwide. UTMB's Sealy Center on Aging has been re-designated by the World Health Organization as a WHO/PAHO Collaborating Center in Aging and Health. UTMB is one of only three institutions in the United States to receive this designation.

Contact: Molly Dannenmaier
University of Texas Medical Branch at Galveston

Public Release: 15-Dec-2014
American Journal of Transplantation
Simple steps can safeguard against Ebola transmission through organ donation
While serious infections can be transmitted from donated organs, the risk of passing Ebola virus disease from an organ donor to a recipient is extremely small.

Contact: Evelyn Martinez

Public Release: 14-Dec-2014
Potential cure for hepatitis B enters phase 1/2a clinical trial
A new treatment developed by Walter and Eliza Hall Institute researchers to promote the cure of chronic hepatitis B virus infection is now recruiting patients for a phase I/2a clinical trial.
TetraLogic Pharmaceuticals

Contact: Alan Gill
Walter and Eliza Hall Institute

Public Release: 12-Dec-2014
PLOS Medicine
A matter of birth and death: Unsafe conditions still killing new mothers and newborns
New publication reports that a lack of safe water, sanitation and hygiene in birth settings is killing mothers and newborns in the developing world. Call by nine leading health organizations, including the London School of Hygiene & Tropical Medicine and WaterAid, for governments to act to save lives and enable skilled health workers to do their jobs.
Sanitation and Hygiene Applied Research for Equity Consortium

Contact: Jenny Orton
London School of Hygiene & Tropical Medicine

Public Release: 11-Dec-2014
Cause of malaria drug resistance in SE Asia identified
Malaria drug resistance in Southeast Asia is caused by a single mutated gene in the disease-causing parasite, a Columbia-led study has found.
National Institutes of Health

Contact: Lucky Tran
Columbia University Medical Center

Public Release: 11-Dec-2014
International Journal of Infectious Diseases
Middle East respiratory syndrome coronavirus unlikely to reach epidemic status
In three new studies in the International Journal of Infectious Disease, researchers reported on clinical outcomes in the Kingdom of Saudi Arabia, how long patients will shed virus during their infections, and how the Sultanate of Oman is dealing with cases that have appeared there. An editorial in the same issue discusses how the relatively high percentage of infections has been hospital-acquired, which reduces the possibility that MERS-CoV will reach pandemic or even epidemic status.

Contact: Fiona Macnab
Elsevier Health Sciences

Public Release: 11-Dec-2014
Scientists closing in on an new type of vaccine
When we acquire diarrhea on a vacation, it is often caused by a bacterial infection. Now a Danish research team is working on a new type of vaccine design targeting the disease causing bacterium -- if it works it may very well revolutionize not only the prevention of this disease, but also offer protection against other pathogens with a heavy disease burden such as Mycobacterium tuberculosis and antibiotic-resistant Staphylococcus aureus (MRSA). The project is supported with a 2.93 million DKK Novo Pre-Seed grant (393.677 €) from Novo Seeds, which is part of the Novo Nordisk Foundation and Novo A/S as well as the University of Southern Denmark's internal Proof of Concept Board.
Novo Nordisk Foundation, University of Southern Denmark

Contact: Birgitte Svennevig
University of Southern Denmark

Public Release: 11-Dec-2014
Maternal and Child Health Journal
Poor diet links obese mothers and stunted children
Malnutrition is a major cause of stunted growth in children, but new UCL research on mothers and children in Egypt suggests that the problem is not just about quantity of food but also quality.

Contact: Harry Dayantis
University College London

Public Release: 10-Dec-2014
Environmental Science & Technology Letters
How long can Ebola live?
The Ebola virus travels from person to person through direct contact with infected body fluids. But how long can the virus survive on glass surfaces or countertops? How long can it live in wastewater when liquid wastes from a patient end up in the sewage system? In an article published in the journal Environmental Science & Technology Letters, Kyle Bibby of the University of Pittsburgh reviews the latest research to find answers to these questions.

Contact: Cara Masset
University of Pittsburgh

Public Release: 10-Dec-2014
Journal of Biological Chemistry
New Notre Dame study examines important Ebola protein
A new study by Robert Stahelin, an adjunct associate professor of chemistry and biochemistry at the University of Notre Dame and an associate professor at the Indiana University School of Medicine-South Bend, as well as a member of Notre Dame's Eck Institute for Global Health, investigates how the most abundant protein that composes the Ebola virus, VP 40, mediates replication of a new viral particle.

Contact: Robert Stahelin
University of Notre Dame

Showing releases 1001-1025 out of 1284.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>